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With over 8 million new cases in 2010, particularly
documented in developing countries, tuberculosis (TB)
is still a highly present pandemic and often terminal [1].
This is also due to the emergence of antibiotic-resistant
strains (MDR-TB and XDR-TB) of the primary causative
agent Mycobacterium tuberculosis (MTB). Efforts to
develop new effective drugs against MTB are restrained
by the unique and largely impermeable mycobacterial
cell wall [2]. Accordingly, tools for estimating the ability
of chemical compounds to pass this barrier would sig-
nificantly support TB drug discovery.
Using the CDD TB database of antimycobacterial sub-
stances [3], 3,815 active and, thus, permeable compounds
could be retrieved. A data mining approach was conducted
to gather the similarities of these substances in terms of
physico-chemical descriptors and to delimit them from a
generic dataset of drug-like molecules. Principal compo-
nent analyses were performed and a logistic regression
model was generated on the basis of the differences of
these datasets in the first principal component. This
regression model was thoroughly evaluated using highly
active MTB inhibitors absent in the training dataset, as
well as inhibitors of the validated MTB drug target InhA.
Based on these validation results, its performance is
expected to be of high practical value for virtual screening
purposes. The regression model was implemented into the
online tool MycPermCheck to predict the permeability
probability of small organic compounds against the MTB
cell wall. Given the current lack of precise molecular cri-
teria determining mycobacterial permeability, MycPerm-
Check represents an unprecedented knowledge-driven
prediction tool intended to support antimycobacterial
drug discovery. It can be used intuitively as an additional
selection criterion for potential new inhibitors against
MTB. The MycPermCheck online tool is freely accessible
under the URL: http://www.mycpermcheck.aksotriffer.
pharmazie.uni-wuerzburg.de.
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